adenosine has been researched along with Benign Neoplasms, Brain in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (13.24) | 18.7374 |
1990's | 3 (4.41) | 18.2507 |
2000's | 7 (10.29) | 29.6817 |
2010's | 23 (33.82) | 24.3611 |
2020's | 26 (38.24) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Gao, Z; Li, F; Li, Y; Liu, Q; Long, T; Long, W; Pan, Y; Qin, C; Sun, Z; Yi, Y; Yu, J; Zhang, C; Zhao, W | 1 |
Arab, S; Hasannejad, F | 1 |
Chen, W; Li, T; Miao, YQ; Shen, Q; Sun, Y; Wang, SC; Zhou, J | 1 |
Chen, L; Hansen, LJ; He, Y; Pirozzi, CJ; Roso, K; Wang, W; Yang, Q; Yang, R | 1 |
Agnihotri, S; Dixit, D; Gimple, RC; Godugu, B; Lee, D; Li, X; Lv, D; Prager, BC; Qiu, Z; Rich, JN; Shen, JZ; Wang, X; Wu, Q; Xie, Q; Yang, K; Zhang, G; Zhao, L; Zhong, C | 1 |
Chen, Z; Yan, Z; Zhang, M; Zhang, W | 1 |
Alarcón, S; Delgado, J; Erices, JI; Fernández-Gajardo, R; Melo, R; Niechi, I; Quezada Monrás, C; Rocha, JD; Salazar-Onfray, F; San Martín, R; Uribe, D | 1 |
Ait Ssi, S; Badou, A; Ghouzlani, A; Kandoussi, S; Lakhdar, A; Naji, O; Rafii, S | 1 |
Li, F; Zhang, C; Zhang, G | 1 |
Erices, JI; Niechi, I; Quezada, C; Richter, HG; Rocha, JD; San Martín, R; Silva, P; Torres, Á; Uribe, D; Uribe-Ojeda, A | 1 |
Chen, L; Chen, Z; Deng, Q; Dinglin, X; Hou, X; Huang, H; Li, D; Ling, Y; Lv, Z; Ma, S; Peng, Y; Wang, H; Wu, Y | 1 |
Guo, J; Li, J; Lin, F; Wang, W; Zhao, J | 1 |
Abbracchio, MP; Ceruti, S | 2 |
Cao, Y; Chen, L; Chen, X; Li, L; Zhou, C | 1 |
Ciafrè, SA; Galardi, S; Michienzi, A | 1 |
Azambuja, JH; Battastini, AMO; Beckenkamp, LR; Braganhol, E; Figueiró, F; Iser, IC; Lenz, GS; Michels, LR; Roliano, GG; Scholl, JN; Schuh, RS; Sévigny, J; Stefani, MA; Teixeira, HF; Wink, MR | 1 |
Alarcón, S; Ayuso Sacido, A; Fernández, R; Melo, R; Quezada, C; San Martín, R; Toro, MLÁ; Uribe, D; Villarreal, C | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Giacomelli, C; Marchetti, L; Martini, C; Pietrobono, D; Trincavelli, ML | 1 |
Chang, G; Han, L; He, C; Huang, S; Huo, L; Huse, JT; Li, P; Ma, L; Ma, Y; Shi, H; Shi, L; Tiwary, S; Xie, V; Ye, Y; Zeng, L; Zhang, S; Zhu, J | 1 |
Geng, X; Li, Q; Lin, X; Shi, L; Sun, S; Wang, H; Xi, W; Yu, W; Zhang, Y | 1 |
Dong, J; Du, J; Hou, K; Hu, S; Ji, H; Jin, J; Li, Y; Ma, S; Mi, S; Wang, F; Zhang, C | 1 |
Castresana, JS; De La Rosa, J; Idoate, MA; Meléndez, B; Rey, JA; Urdiciain, A; Zazpe, I; Zelaya, MV | 1 |
An, SY; Chai, RC; Chang, X; Chang, YZ; Jiang, T; Pang, B; Wang, YZ; Zhang, KN | 1 |
Carvalho, TMA; Cascalheira, JF; Costa, AR; Costa, BM; Honório, AC; Marcelino, H; Rosa, CB; Santos, CRA; Sebastião, AM; Teles, FI; Tomás, J | 1 |
Düssmann, H; Juric, V; Lamfers, MLM; Murphy, BM; Prehn, JHM; Rehm, M | 1 |
Fang, C; Geng, X; Hao, L; Li, Q; Liu, F; Song, J; Wang, H; Xiao, M; Xu, J; Zeng, Z; Zhang, Y | 1 |
Chen, Z; Guo, Q; Guo, X; He, Z; Li, B; Li, G; Pan, Z; Qi, Y; Qiu, W; Wang, S; Xue, H; Zhang, P; Zhang, S; Zhao, R; Zhao, S | 1 |
Jiang, XB; Li, XD; Wang, MJ; Wang, X; Wu, YH; Zheng, JL | 1 |
Abate, M; Bifulco, M; Ciaglia, E; Ciuffreda, P; D'Ursi, AM; Gazzerro, P; Grimaldi, M; Laezza, C; Manera, C; Pisanti, S; Ranieri, R; Rodriquez, M; Scrima, M | 1 |
Laddha, SV; Lal, M; Mehani, B; Mukherjee, D; Mukhopadhyay, A; Nayak, S; Paul, D; Ray, A; Sarkar, C; Sharma, A; Sinha, AN; Suri, A | 1 |
Alon, S; Cesarini, V; Eisenberg, E; Gallo, A; Locatelli, F; Silvestris, DA; Tassinari, V; Tomaselli, S | 1 |
Han, L; Hawke, DH; Hwu, P; Jeong, KJ; Labrie, M; Liang, H; Lu, Y; Mills, GB; Mojumdar, K; Peng, X; Scott, KL; Tsang, YH; Wang, Y; Xu, X; Yu, S; Zhang, M; Zhou, Z | 1 |
Arévalo, BR; Brown, NV; Gutiérrez, MC; Luna, VZ; Valdés, FZ | 1 |
Azambuja, JH; Battastini, AMO; Beckenkamp, LR; Braganhol, E; de Oliveira, FH; Fernandes, MC; Figueiró, F; Gelsleichter, NE; Iser, IC; Scholl, JN; Sévigny, J; Spanevello, RM; Stefani, MA; Teixeira, HF; Wink, MR | 1 |
Borodovsky, A; Fretland, AJ; Gangl, E; Goodwin, KJ; Jones, N; Pop-Damkov, P; Sarkar, U; Woessner, R | 1 |
Alarcón, S; Niechi, I; Quezada, C; Sobrevia, L; Toledo, F | 1 |
Chinnaiyan, P; Kant, S; Kesarwani, P; Prabhu, A | 1 |
Huang, B; Huang, QB; Li, XG; Qu, X; Shao, QQ; Sun, JT; Wang, DH; Wang, XY; Xie, Q; Xu, S; Yang, N | 1 |
Joo, KM; Kang, W; Kim, J; Kim, SU; Kim, Y; Nam, DH; Seol, HJ; Seong, DH | 1 |
Kaminska, B; Maleszewska, M; Steranka, A | 1 |
Fernandez, K; Garrido, W; Jaramillo, C; Oyarzun, C; Quezada, C; Rocha, JD; San Martin, R | 1 |
Pomorski, P | 1 |
Barciszewski, J; Boryski, J; Framski, G; Jahnz-Wechmann, Z; Kraszewski, A; Stawinski, J; Szymanska-Michalak, A; Wawrzyniak, D | 1 |
Cui, Q; He, C; Huang, Y; Li, L; Lu, Z; Qu, Q; Riggs, AD; Shi, H; Shi, Y; Sun, G; Yang, CG; Ye, P | 1 |
Battastini, AM; Bavaresco, L; Bernardi, A; Braganhol, E; Cappellari, AR; Delgado-Cañedo, A; Farias, PF; Rockenbach, L; Wink, MR | 1 |
Cohen, PT; Cuthbertson, DJ; Kelsall, IR; Munro, S; Voss, M | 1 |
Ang, BT; Choudhury, Y; Lam, DH; Sandanaraj, E; Tang, C; Tay, FC; Wang, S | 1 |
Abujamra, AL; Battastini, AM; Braganhol, E; Cappellari, AR; Clarimundo, V; Dietrich, F; Glaser, T; Rockenbach, L; Roesler, R; Ulrich, H | 1 |
Alfieri, A; Corte, LD; De Micheli, E; Melani, A; Pedata, F; Pinna, G | 1 |
Bernardi, A; Horn, AP; Jacques-Silva, MC; Lenz, G; Morrone, FB; Rodnight, R; Schwartsmann, G | 1 |
Du, M; Griffin, ME; Hamilton, BJ; Keenan, BJ; Nichols, RC; Roy, KM; Wang, XW; Willson, AM | 1 |
Färber, K; Glass, R; Herrmann, K; Kettenmann, H; Kiwit, J; Kronenberg, G; Markovic, D; Nolte, C; Schnermann, J; Synowitz, M; van Rooijen, N | 1 |
Nagata, K; Nakahata, N; Ohkubo, S | 1 |
Adams, JK; Allan, RG; Cooper, IA; Woodcock, DM | 1 |
Caciagli, F; Caciagli, P; Ciancetta, S; Ciccarelli, R; Di Iorio, P | 1 |
Altiok, N; Fredholm, BB | 1 |
Bradley, KK; Bradley, ME | 1 |
Kalisker, A; Moore, MM; Perkins, JP; Su, YF | 1 |
Baba, T; Fukui, M; Moriguchi, M; Natori, Y; Takeshita, I | 1 |
Fujiwara, S; Fukui, M; Iwaki, T; Kanaide, H; Moriguchi, M; Natori, Y; Takeshita, I | 1 |
Baba, T; Fukui, M; Inoue, T; Nakamura, T; Sakata, S; Takeshita, I; Tashima, T | 1 |
Palmer, GC | 1 |
Baumbach, GL; Bigner, DD; Groothuis, DR; Heistad, DD; Panther, LA; Piegors, D | 1 |
Bigner, DD; Groothuis, DR; Heistad, DH; Molnar, P; Warnke, PC | 1 |
Kodama, T; Matsukado, Y; Shimizu, H | 1 |
Hankiewicz, J; Lesniak, M | 1 |
11 review(s) available for adenosine and Benign Neoplasms, Brain
Article | Year |
---|---|
An overview of current therapeutic strategies for glioblastoma and the role of CD73 as an alternative curative approach.
Topics: 5'-Nucleotidase; Adenosine; Animals; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Mice; Receptor, Adenosine A2B; Tumor Microenvironment | 2022 |
Adenosine Signaling in Glioma Cells.
Topics: Adenosine; Animals; Antineoplastic Agents; Brain Neoplasms; Drug Resistance, Neoplasm; Glioma; Humans; Signal Transduction | 2020 |
Insights into the Regulatory Role of m
Topics: Adenosine; Brain Neoplasms; Cytosine; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Methylation; RNA, Ribosomal, 28S | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Adenosine: Synthetic Methods of Its Derivatives and Antitumor Activity.
Topics: Adenosine; Antineoplastic Agents; Aza Compounds; Brain Neoplasms; Glioblastoma; Humans; Receptors, Purinergic P1; Sulfonic Acids | 2018 |
Glioma progression in diabesity.
Topics: Adenosine; Antineoplastic Agents; Brain Neoplasms; Diabetes Mellitus, Type 2; Disease Progression; Gene Regulatory Networks; Glioma; Humans; Hypoglycemic Agents; Obesity; Risk Factors; Up-Regulation | 2019 |
Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme.
Topics: Adenosine; Antineoplastic Agents; Brain Neoplasms; Drug Resistance, Neoplasm; Glioblastoma; Humans; Multidrug Resistance-Associated Proteins; Neoplastic Stem Cells; Signal Transduction; Tumor Microenvironment | 2014 |
[Nucleotide receptors and the cell motility].
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brain Neoplasms; Cell Movement; Cell Transformation, Neoplastic; Extracellular Matrix; Granulocytes; Humans; Microglia; Neuroglia; Signal Transduction; Uridine Triphosphate | 2014 |
Adenosine signaling in glioma cells.
Topics: Adenosine; Animals; Brain Neoplasms; Glioma; Humans; Signal Transduction | 2013 |
Regulation of cyclic AMP content in normal and malignant brain cells.
Topics: Adenosine; Animals; Brain; Brain Neoplasms; Cerebral Cortex; Cyclic AMP; Hydroxydopamines; Isoproterenol; Kinetics; Nerve Regeneration; Norepinephrine; Papaverine; Phentolamine; Propranolol; Prostaglandins; Rats; Theophylline; Time Factors | 1975 |
Cyclic nucleotides in stroke and related cerebrovascular disorders.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine; Adenylyl Cyclases; Animals; Brain; Brain Ischemia; Brain Neoplasms; Capillaries; Cerebrovascular Disorders; Cyclic AMP; Cyclic GMP; gamma-Aminobutyric Acid; Guanylate Cyclase; Humans; Hypoxia, Brain; In Vitro Techniques; Lactates; Lactic Acid; Norepinephrine; Phospholipids; Protein Kinases; Synaptic Membranes; Tissue Distribution | 1985 |
1 trial(s) available for adenosine and Benign Neoplasms, Brain
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
57 other study(ies) available for adenosine and Benign Neoplasms, Brain
Article | Year |
---|---|
Interplay of m
Topics: Adenosine; Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Glioblastoma; Histone Code; Humans; Mice; Mice, Inbred BALB C; Temozolomide | 2021 |
N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
Topics: Adenosine; Animals; Argininosuccinate Synthase; Brain Neoplasms; Case-Control Studies; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioma; Humans; Male; Methyltransferases; Mice; Neoplasm Transplantation; Prognosis; RNA-Binding Proteins; Survival Analysis | 2022 |
MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization.
Topics: Adenosine; Brain Neoplasms; Glioblastoma; Humans; Macrophages; Tumor Microenvironment | 2022 |
PDGF signaling inhibits mitophagy in glioblastoma stem cells through N
Topics: Adenosine; Brain Neoplasms; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Methyltransferases; Mitophagy; Neoplastic Stem Cells; Platelet-Derived Growth Factor | 2022 |
Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma.
Topics: Adenosine; Brain Neoplasms; Glioma; Humans; MicroRNAs; Prognosis; RNA, Long Noncoding; Tumor Microenvironment | 2023 |
A
Topics: Adenosine; Brain Neoplasms; Drug Resistance, Neoplasm; Glioblastoma; Humans; Hypoxia; Multidrug Resistance-Associated Proteins; Neoplastic Stem Cells; Receptor, Adenosine A2B; Receptors, Purinergic P1 | 2022 |
A
Topics: Adenosine; Astrocytoma; Brain Neoplasms; Glioma; Humans; Immunotherapy; Male; Prognosis; Receptor, Adenosine A2A | 2023 |
m6A RNA Methylation Controls Proliferation of Human Glioma Cells by Influencing Cell Apoptosis.
Topics: Adenosine; Apoptosis; Brain Neoplasms; Cell Line; Cell Movement; Cell Proliferation; Glioma; Humans; Methylation; Methyltransferases | 2019 |
Adenosine Depletion as A New Strategy to Decrease Glioblastoma Stem-Like Cells Aggressiveness.
Topics: Adenosine; Antineoplastic Agents, Phytogenic; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Adhesion; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Glioblastoma; Humans; Hypoxia; Neoplasm Invasiveness; Neoplastic Stem Cells; Tumor Cells, Cultured; Vincristine | 2019 |
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.
Topics: Adenosine; Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; MicroRNAs; Models, Biological; Neovascularization, Pathologic; RNA Interference; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2019 |
Identification of N
Topics: Adenosine; Brain Neoplasms; China; Cohort Studies; Computational Biology; Databases, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Isocitrate Dehydrogenase; Microarray Analysis; Prognosis; Progression-Free Survival; RNA, Long Noncoding; Survival Analysis | 2021 |
Adenosine A2A receptor activation reduces brain metastasis via SDF-1/CXCR4 axis and protecting blood-brain barrier.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Benzylamines; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Phenethylamines; Receptor, Adenosine A2A; Receptors, CXCR4; Xenograft Model Antitumor Assays | 2020 |
Blockade of CD73 delays glioblastoma growth by modulating the immune environment.
Topics: 5'-Nucleotidase; Adenosine; Animals; Brain Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Glioma; Immunohistochemistry; Immunotherapy; Macrophages; Microglia; Rats | 2020 |
Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells.
Topics: 5'-Nucleotidase; Acid Phosphatase; Adenosine; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Equilibrative Nucleoside Transporter 1; Extracellular Space; Glioblastoma; GPI-Linked Proteins; Humans; Neoplastic Stem Cells | 2020 |
High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome.
Topics: Adenosine; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Extracellular Space; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mesenchymal Stem Cells; Neoplasm Invasiveness; Phosphorylation | 2020 |
YTHDF3 Induces the Translation of m
Topics: 5' Untranslated Regions; Adenosine; Animals; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Mice; Neoplasm Transplantation; RNA-Binding Proteins; Survival Analysis; Up-Regulation | 2020 |
Screening and functional prediction of differentially expressed circular RNAs in human glioma of different grades.
Topics: Adenosine; Adult; Aged; Brain Chemistry; Brain Neoplasms; Computational Biology; Female; Gene Regulatory Networks; Glioma; High-Throughput Nucleotide Sequencing; Humans; Male; Mass Screening; Metabolic Networks and Pathways; Middle Aged; Neoplasm Grading; Open Reading Frames; Predictive Value of Tests; RNA, Circular | 2020 |
m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biomarkers, Tumor; Brain Neoplasms; DNA Copy Number Variations; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioma; Humans; Immunity, Innate; Lymphocytes, Tumor-Infiltrating; Machine Learning; Methyltransferases; Mutation Rate; Phenotype; Prognosis; RNA-Binding Proteins; Tumor Microenvironment | 2021 |
APR-246 combined with 3-deazaneplanocin A, panobinostat or temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Colony-Forming Units Assay; Drug Screening Assays, Antitumor; Drug Synergism; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mutation; Panobinostat; Quinuclidines; Temozolomide; Tumor Suppressor Protein p53 | 2021 |
METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
Topics: Adenosine; Animals; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; ELAV-Like Protein 1; Female; Glioma; Heterografts; Humans; Isocitrate Dehydrogenase; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; RNA, Long Noncoding; Signal Transduction | 2021 |
Adenosine Inhibits Cell Proliferation Differently in Human Astrocytes and in Glioblastoma Cell Lines.
Topics: Adenosine; Astrocytes; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioblastoma; Humans | 2021 |
Transcriptional CDK Inhibitors CYC065 and THZ1 Induce Apoptosis in Glioma Stem Cells Derived from Recurrent GBM.
Topics: AC133 Antigen; Adenosine; Adult; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Glioma; Humans; Hyaluronan Receptors; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Temozolomide | 2021 |
Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma.
Topics: Adenosine; Brain Neoplasms; Glioblastoma; Humans; RNA Processing, Post-Transcriptional; RNA, Circular; Transcriptome | 2021 |
The N
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Brain; Brain Neoplasms; Cell Line, Tumor; Datasets as Topic; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioblastoma; HSP70 Heat-Shock Proteins; Humans; Immune Checkpoint Inhibitors; Kaplan-Meier Estimate; Osteopontin; Programmed Cell Death 1 Receptor; Protein-Lysine 6-Oxidase; RNA-Seq; Transcription Factors; Treatment Outcome; Tumor Microenvironment; Tumor-Associated Macrophages; YAP-Signaling Proteins | 2021 |
Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells.
Topics: Adenosine; Aerobiosis; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Demethylation; Disease Progression; Drug Resistance, Neoplasm; Glioblastoma; Glycolysis; Humans; Neoplasm Proteins; Prognosis; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA, Long Noncoding; RNA, Messenger; Temozolomide | 2021 |
The isoprenoid derivative N
Topics: Adenosine; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Humans; Mevalonic Acid; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Terpenes | 2017 |
A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme.
Topics: Adenosine; Adenosine Deaminase; Autopsy; Base Pairing; Brain Neoplasms; Case-Control Studies; Corpus Callosum; Frontal Lobe; Gene Expression Regulation, Neoplastic; Gene Library; Glioblastoma; Gray Matter; HEK293 Cells; Humans; Inosine; MicroRNAs; Nucleic Acid Conformation; RNA Editing; RNA Stability; RNA-Binding Proteins; Thermodynamics; White Matter | 2017 |
ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.
Topics: Adenosine; Adenosine Deaminase; Adult; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; HEK293 Cells; Humans; Inosine; Male; MicroRNAs; Neoplasm Invasiveness; RNA Editing; RNA-Binding Proteins | 2018 |
A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.
Topics: Adenosine; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Databases, Genetic; Gene Expression Regulation, Neoplastic; Humans; Inosine; Proteomics; RNA Editing; Sequence Analysis, RNA; Tandem Mass Spectrometry | 2018 |
CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth.
Topics: 5'-Nucleotidase; Adenosine; Animals; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Down-Regulation; Gene Knockdown Techniques; Glioblastoma; Humans; Matrix Metalloproteinase 2; Neoplasm Invasiveness; NF-kappa B; Proto-Oncogene Proteins c-akt; Rats; Receptors, Purinergic P1; Signal Transduction; Temozolomide; Vimentin | 2019 |
Development of a quantification method for adenosine in tumors by LC-MS/MS with dansyl chloride derivatization.
Topics: Adenosine; Animals; Brain Neoplasms; Calibration; Chromatography, Liquid; Liver Neoplasms; Mice; Tandem Mass Spectrometry | 2019 |
Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma.
Topics: Adenosine; Adult; Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Gene Expression Profiling; Glioblastoma; Humans; Macrophages; Metabolic Networks and Pathways; Metabolome; Metabolomics; Mice; Mice, Inbred C57BL; T-Lymphocytes, Regulatory; Tryptophan | 2019 |
Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas.
Topics: 5'-Nucleotidase; Adenosine; Antigens, CD; Apyrase; Brain Neoplasms; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Glioma; Humans; Immune Tolerance; Lymphocytes, Tumor-Infiltrating | 2013 |
Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
Topics: Adenosine; Animals; Antimetabolites, Antineoplastic; Apoptosis; Blood-Brain Barrier; Blotting, Western; Brain Neoplasms; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Cytosine Deaminase; Drug Synergism; Female; Fetus; Flucytosine; Fluorouracil; Genetic Engineering; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neural Stem Cells; Prodrugs; Vasodilator Agents; Xenograft Model Antitumor Assays | 2013 |
The effects of selected inhibitors of histone modifying enzyme on C6 glioma cells.
Topics: Acetylation; Adenosine; Animals; Azepines; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Epigenesis, Genetic; Glioma; Histones; Hydroxamic Acids; Piperazines; Quinazolines; Rats; Valproic Acid | 2014 |
Searching for anti-glioma activity. Ribonucleoside analogues with modifications in nucleobase and sugar moieties.
Topics: Adenosine; Antineoplastic Agents; Brain Neoplasms; Cytidine; Drug Screening Assays, Antitumor; Furans; Glioblastoma; Guanosine; HeLa Cells; Humans; Inhibitory Concentration 50 | 2016 |
m
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Base Sequence; Brain Neoplasms; Carcinogenesis; Cell Differentiation; Cell Proliferation; Cell Self Renewal; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioblastoma; Humans; Meclofenamic Acid; Methylation; Methyltransferases; Mice; Neoplastic Stem Cells; RNA; RNA, Messenger | 2017 |
The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Affinity Labels; Animals; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glioma; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Rats; Thioinosine | 2008 |
R3F, a novel membrane-associated glycogen targeting subunit of protein phosphatase 1 regulates glycogen synthase in astrocytoma cells in response to glucose and extracellular signals.
Topics: Adenosine; Adrenergic alpha-Agonists; Amino Acid Sequence; Animals; Astrocytoma; Brain; Brain Neoplasms; Carrier Proteins; Cell Line, Tumor; DNA; Extracellular Space; Glucose; Glycogen; Glycogen Synthase; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mutagenesis; Norepinephrine; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 1; RNA; Signal Transduction; Subcellular Fractions | 2011 |
Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells.
Topics: Adenosine; Animals; Brain Neoplasms; Cell Line, Tumor; Female; Glioblastoma; Humans; Inosine; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; RNA Editing; RNA, Neoplasm; Sequence Analysis, RNA; Transplantation, Heterologous | 2012 |
Characterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Adenosine Monophosphate; Adenosine Triphosphate; Alkaline Phosphatase; beta Catenin; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cerebellum; Child; Diphosphates; Gene Expression Regulation, Neoplastic; Humans; Medulloblastoma; Neoplasm Metastasis; Organ Specificity; Phosphoric Diester Hydrolases; Prognosis; Pyrophosphatases; Signal Transduction | 2012 |
Adenosine extracellular levels in human brain gliomas: an intraoperative microdialysis study.
Topics: Adenosine; Adult; Aged; Brain Neoplasms; Chromatography, High Pressure Liquid; Extracellular Space; Female; Glioma; Humans; Intraoperative Period; Male; Microdialysis; Middle Aged | 2003 |
Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Brain Neoplasms; Cell Division; DNA; Extracellular Space; Glioma; Humans; Nucleosides; Nucleotides; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Purines; Pyrimidines; Receptors, Purinergic P1; Receptors, Purinergic P2; Signal Transduction; Thymidine; Tumor Cells, Cultured; Uridine Diphosphate; Uridine Triphosphate | 2003 |
Post-transcriptional regulation of glucose transporter-1 by an AU-rich element in the 3'UTR and by hnRNP A2.
Topics: 3' Untranslated Regions; Adenosine; Base Sequence; Brain Neoplasms; Cell Line; Cell Line, Tumor; Cytoplasm; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Glioblastoma; Glucose Transporter Type 1; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Molecular Sequence Data; Monosaccharide Transport Proteins; Protein Binding; Protein Isoforms; RNA-Binding Proteins; RNA, Messenger; Transcription, Genetic; Up-Regulation; Uridine | 2004 |
A1 adenosine receptors in microglia control glioblastoma-host interaction.
Topics: Adenosine; Animals; Brain Neoplasms; Cell Communication; Cell Division; Cells, Cultured; Genes, Reporter; Genotype; Glioblastoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microglia; Receptor, Adenosine A1 | 2006 |
Adenosine uptake-dependent C6 cell growth inhibition.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine; Adenosine Deaminase; Adenosine Diphosphate; Adenosine Kinase; Adenosine Monophosphate; Animals; Brain Neoplasms; Cell Count; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Dipyridamole; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Glioma; Hydrolysis; Rats; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Thioinosine; Uridine | 2007 |
Effect of several inhibitors of enzymatic DNA methylation on the in vivo methylation of different classes of DNA sequences in a cultured human cell line.
Topics: 5-Methylcytosine; Adenosine; Azacitidine; Brain Neoplasms; Cell Division; Cell Line; Cycloleucine; Cytosine; Deoxyadenosines; DNA; DNA Replication; Ethionine; Homocysteine; Humans; Methylation; Thionucleosides; Tubercidin | 1983 |
Adenosine--norepinephrine interactions on cyclic AMP generating system in human tumoral brain slices.
Topics: Adenosine; Adult; Aged; Brain Neoplasms; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Female; Glioblastoma; Humans; In Vitro Techniques; Male; Middle Aged; Norepinephrine; Propranolol; Theophylline | 1982 |
Bradykinin inhibits cyclic AMP accumulation in D384-human astrocytoma cells via a calcium-dependent inhibition of adenylyl cyclase.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Astrocytoma; Bradykinin; Brain Neoplasms; Calcimycin; Calcium; Calmodulin; Colforsin; Cyclic AMP; Dopamine; Egtazic Acid; Humans; Hydroquinones; Inositol 1,4,5-Trisphosphate; Neoplasm Proteins; Pyrrolidinones; Rolipram; Signal Transduction; Tumor Cells, Cultured | 1993 |
Purine nucleoside-dependent inhibition of cellular proliferation in 1321N1 human astrocytoma cells.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Astrocytoma; Brain Neoplasms; Cell Death; Cell Division; Humans; Purine Nucleosides; Purinergic P1 Receptor Antagonists; Theophylline; Tumor Cells, Cultured; Uridine Triphosphate | 2001 |
Effects of theophylline on the selective increases in intratumoral blood flow induced by intracarotid infusion of adenosine and adenosine triphosphate in C6 glioma-transplanted rat brains.
Topics: Adenosine; Adenosine Triphosphate; Animals; Blood Flow Velocity; Brain Neoplasms; Carotid Arteries; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Drug Interactions; Glioma; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Theophylline | 1992 |
Effects of L-NMMA and L-NNA on the selective ATP-induced enhancement of intratumoral blood flow.
Topics: Adenosine; Adenosine Triphosphate; Animals; Arginine; Brain Neoplasms; Glioma; Male; Nitroarginine; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Regional Blood Flow; Tumor Cells, Cultured | 1992 |
Selective enhancement of intratumoural blood flow in malignant gliomas: experimental study in rats by intracarotid administration of adenosine or adenosine triphosphate.
Topics: Adenosine; Adenosine Triphosphate; Animals; Blood Flow Velocity; Brain Neoplasms; Cerebrovascular Circulation; Glioma; Injections, Intravenous; Male; Neoplasm Transplantation; Rats; Rats, Inbred Strains | 1989 |
Vasoactive drugs produce selective changes in flow to experimental brain tumors.
Topics: Adenosine; Animals; Blood-Brain Barrier; Brain Neoplasms; Carbon Dioxide; Cerebrovascular Circulation; Dogs; Norepinephrine; Sarcoma, Avian; Vasodilation | 1985 |
Intravenous adenosine selectively increases blood flow to xenotransplanted intracerebral gliomas.
Topics: Adenosine; Animals; Brain Neoplasms; Cerebrovascular Circulation; Glioma; Infusions, Intravenous; Neoplasm Transplantation; Rats; Transplantation, Heterologous | 1987 |
The cyclic AMP system of human brain.
Topics: Adenine; Adenosine; Adenylyl Cyclases; Adult; Aged; Brain; Brain Chemistry; Brain Neoplasms; Carbon Isotopes; Cerebral Cortex; Child, Preschool; Cyclic AMP; Epinephrine; Female; Histamine; Humans; Intracranial Aneurysm; Isoproterenol; Male; Middle Aged; Norepinephrine; Phosphoric Diester Hydrolases; Serotonin; Tritium; Veratrine | 1973 |
Adenosine deaminase in cerebrospinal fluid.
Topics: Adenosine; Adolescent; Adult; Aged; Aminohydrolases; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebellum; Cerebrospinal Fluid Proteins; Cerebrovascular Disorders; Child; Chlorides; Epilepsy; Female; Glioma; Glucose; Humans; Male; Meningioma; Meningitis; Middle Aged | 1972 |